Loading company…
Surf Therapeutics develops non-invasive ultrasound neuromodulation for chronic inflammatory disorders.
Founded in 2023 and based in Austin, US, Surf Therapeutics develops an ultrasound neuromodulation platform for chronic inflammatory conditions. Its technology uses acoustic energy to engage the cholinergic anti-inflammatory pathway. In April 2026, the company raised venture funding from Xcellerant Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in